Search results

Back
1 - 10 of 28 Search results


    - 3 mins read

 - 3 mins read

5 Ways Ipsen Keeps Compliance at Our Core

It’s no secret that the biotech and pharma industries are highly regulated and for very good reason. We have an important role to play in ensuring new, innovative medicines reach the people who need them. But the rules that govern our industry are comple...


  

Charitable Contributions 

...


  

Home

...


  

Investigator Sponsored Studies

...



    - 

 - 

Ipsen’s Onivyde® regimen, a potential new standard-of-care first-line therapy in metastatic pancreatic adenocarcinoma, approved by FDA  

PARIS, FRANCE, 13 February 2024 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application for Onivyde® (irinotecan liposome injection) plus oxaliplatin, fluorour...


    - 

 - 

Module 1 – banner_Environment [Responsibility]_1920x280pix

...


    - 

 - 

Module 1 – banner_Governance [Responsibility]_1920x280pix

...


1 2 3